RENAL CANCER STAGE I

This adverse event was reported 2620 times

These drugs are most commonly taken by patients reporting RENAL CANCER STAGE I:

# Drug Count
0 RANITIDINE 399
1 RANITIDINE HYDROCHLORIDE 169
2 ADALIMUMAB 8
3 TACROLIMUS 7
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 6
5 TACROLIMUS OINTMENT 0.1% 6
6 ESOMEPRAZOLE MAGNESIUM 5
7 GABAPENTIN 5
8 PREDNISONE 5
9 SIROLIMUS 5
See all common drugs associated with RENAL CANCER STAGE I

RENAL CANCER STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RANITIDINE HYDROCHLORIDE 169 0.0031
1 RANITIDINE 399 0.0020
2 PROBENECID 1 0.0008
3 SIROLIMUS 5 0.0004
4 INFLIXIMAB-DYYB 1 0.0003
5 PEGVISOMANT 1 0.0002
6 LANTHANUM CARBONATE 1 0.0002
7 AMLODIPINE BESYLATE AND VALSARTAN 2 0.0002
8 MAGNESIUM SULFATE HEPTAHYDRATE 2 0.0002
9 TRIAMTERENE 1 0.0001
See all drugs enriched for association with RENAL CANCER STAGE I